Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein

This publication has 26 references indexed in Scilit:

• Low-density lipoprotein modification occurring in human plasma
  Atherosclerosis, 1998
• Polyacrylamide-based glycoconjugates as tools in glycobiology
  Glycoconjugate Journal, 1998
• Metabolism of Native and Naturally Occurring Multiple Modified Low Density Lipoprotein in Smooth Muscle Cells of Human Aortic Intima
  Experimental and Molecular Pathology, 1997
• Apolipoprotein B-Bound Lipids as a Marker for Evaluation of Low Density Lipoprotein Oxidation in Vivo
  Biochemical and Biophysical Research Communications, 1995
• Desialylated low density lipoprotein - naturally occurring modified lipoprotein with atherogenic potency
  Atherosclerosis, 1991
• Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: Separation from native lipoprotein by affinity chromatography
  Biochemical and Biophysical Research Communications, 1990
• Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients
  Biochemical and Biophysical Research Communications, 1989
• Sialic‐Acid Content of Low‐Density Lipoproteins Controls Their Binding and Uptake by Cultured Cells
  European Journal of Biochemistry, 1979
• International Committee for Standardization in Haematology: Recommended Methods for Red‐Cell Enzyme Analysis*
  British Journal of Haematology, 1977
• Neuraminic acid-specific modification and tritium labelling of gangliosides
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977